NEW YORK, Sept. 24, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross
LLP is investigating claims on behalf of investors of Greenway
Medical Technologies, Inc. ("Greenway" or the "Company") (NYSE:
GWAY) (ISIN: US39679B1035) (CUSIP: 39679B103) concerning the
proposed acquisition of Greenway by Vista Equity Partners III, LLC
in a transaction valued at approximately $644 million.
The investigation concerns whether the Greenway directors are
breaching their fiduciary duties by failing to adequately shop the
Company and maximize shareholder value. Under the terms of
the agreement, Greenway shareholders will receive $20.35 per share in cash for each share of
Greenway common stock. However, synergies may not be fully
reflected in offered price.
Greenway shareholders seeking more information about this
acquisition are advised to contact Robert
Willoughby at rswilloughby@pomlaw.com or 212-661-1100 or
888-476-6529, ext. 237.
The firm is also investigating actions on behalf of shareholders
for the following companies: Official Payments Holdings,
Inc., and Eastern Insurance Holdings, Inc.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and San
Diego, is acknowledged as one of the premier firms in the
areas of corporate, securities, and antitrust class litigation.
Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the
Pomerantz Firm pioneered the field of securities class actions.
Today, more than 75 years later, the Pomerantz Firm continues in
the tradition he established, fighting for the rights of the
victims of securities fraud, breaches of fiduciary duty, and
corporate misconduct. The Firm has recovered numerous
multimillion-dollar damages awards on behalf of defrauded
investors. See www.pomerantzlaw.com.
CONTACT:
Robert
Willoughby
Pomerantz Grossman Hufford Dahlstrom
& Gross LLP
212-661-1100 ext. 237
rswilloughby@pomlaw.com
SOURCE Pomerantz Grossman Hufford
Dahlstrom & Gross LLP